(Q35547316)

8 August 2017

title

Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis? (English)

1 reference

8 August 2017

0 references

Lems WF

1

1 reference

8 August 2017

Jacobs JW

2

1 reference

8 August 2017

Bijlsma JW

3

1 reference

8 August 2017

van Veen GJ

4

1 reference

8 August 2017

Houben HH

5

1 reference

8 August 2017

Haanen HC

6

1 reference

8 August 2017

Gerrits MI

7

1 reference

8 August 2017

van Rijn HJ

8

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

Annals of the Rheumatic Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

56

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

357-363

1 reference

THE EFFECTS OF SODIUM FLORIDE ON CALCIUM METABOLISM OF SUBJECTS WITH METABOLIC BONE DISEASES

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Phosphotyrosyl protein phosphatases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Fluoride and bone--quantity versus quality.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Pre-existing fractures and bone mass predict vertebral fracture incidence in women

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Slow-release sodium fluoride in osteoporosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

How to assess drug efficacy in osteoporosis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1752400

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

26 September 2018

1 reference

12 December 2020

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study

1 reference

12 December 2020

Biochemical markers of bone turnover

1 reference

12 December 2020

Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis

1 reference

12 December 2020

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

1 reference

12 December 2020

Generalised bone loss in patients with early rheumatoid arthritis

1 reference

12 December 2020

Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss

1 reference

12 December 2020

Sodium monofluorophosphate increases vertebral bone mineral density in patients with corticosteroid-induced osteoporosis

1 reference

12 December 2020

Determination of pyridinoline and deoxypyridinoline in urine, with special attention to retaining their stability

1 reference

12 December 2020

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis

1 reference

12 December 2020

Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids

1 reference

12 December 2020

Fluoride: the verdict is in, but the controversy lingers

1 reference

12 December 2020

The long-term treatment of steroid osteoporosis with fluoride

1 reference

12 December 2020

Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy

1 reference

12 December 2020

Corticosteroid-induced osteoporosis: effects of a treatment with slow-release sodium fluoride

1 reference

12 December 2020

Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay

1 reference

12 December 2020

Pathogenesis of osteoporosis

1 reference

12 December 2020

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

12 December 2020

Steroid-induced fractures and bone loss in patients with asthma

1 reference

12 December 2020

Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome

1 reference

12 December 2020

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

12 December 2020

Corticosteroid-induced osteoporosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.56.6.357

1 reference

8 August 2017

1 reference

8 August 2017

1 reference